PPP 784 DURICEF 500 mg (Duricef 500 mg)
Generic Name: cefadroxil
Pill with imprint PPP 784 DURICEF 500 mg is Red / White, Capsule-shape and has been identified as Duricef 500 mg. It is supplied by Bristol-Myers Squibb.
Duricef is used in the treatment of skin and structure infection; impetigo; urinary tract infection; bacterial endocarditis prevention; kidney infections (and more), and belongs to the drug class first generation cephalosporins. There is no proven risk in humans during pregnancy. Duricef 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for PPP 784 DURICEF 500 mg
Duricef
- Generic Name:
- cefadroxil
- Imprint:
- PPP 784 DURICEF 500 mg
- Strength:
- 500 mg
- Color:
- Red / White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- First generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00087-0784
More about Duricef (cefadroxil)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: first generation cephalosporins
Consumer resources
- Duricef
- Duricef (Cefadroxil Capsules and Tablets)
- Duricef (Cefadroxil Suspension)
- Duricef (Advanced Reading)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
